Eagle Genomics raised €20M in a funding round in Nov 2022. The company is based in Cambridge, UK. Investors in the round: abrdn plc, Environmental Technologies Fund, Granpool Innovative Investments. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
